EMMA DEMORIER: Open Payments
NPI 1083151559 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,376 in 69 payments from 18 companies in 2025. Trend: 2023 $387 · 2024 $1,366 · 2025 $1,376
Food & beverage: $1,376
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $275 |
| Otsuka America Pharmaceutical, Inc. | 9 | $204 |
| Janssen Pharmaceuticals, Inc | 6 | $131 |
| Axsome Therapeutics, Inc. | 5 | $100 |
| Indivior Inc. | 3 | $80 |
| Teva Pharmaceuticals USA, Inc. | 4 | $79 |
| Alkermes, Inc. | 3 | $76 |
| Bausch Health US, LLC | 4 | $70 |
| Vanda Pharmaceuticals Inc. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
Products named: VRAYLAR, REXULTI, SPRAVATO, Auvelity, SUBLOCADE, ARISTADA, ABILIFY ASIMTUFII, APLENZIN.
Industry payments across NC — which companies pay providers there.
